Email This Article
This Is No Time to Be Buying Pfizer
By
Lissa Morgenthaler
10/22/01 - 07:39 AM EDT
The company's fairly valued already, and at least one of its blockbuster drugs, Lipitor, is looking vulnerable.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.










View Directory